This case may help medical oncologists/hematologists recognize IgM‐MGRS as a diagnostic consideration in patients with unexplained renal impairment and IgM monoclonal gammopathy, and may inform treatment decisions in similar clinical contexts. This evidence concerns the gene CD40LG and monoclonal gammopathy.